PharmAthene, Inc.  

(Public, NYSEMKT:PIP)   Watch this stock  
Find more results for NYSEAMEX:PIP
1.84
-0.02 (-1.08%)
Sep 17 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 1.83 - 1.94
52 week 1.19 - 2.59
Open 1.87
Vol / Avg. 446,428.00/775,487.00
Mkt cap 104.98M
P/E     -
Div/yield     -
EPS -0.21
Shares 56.44M
Beta 1.51
Inst. own 35%
Sep 22, 2014
PharmAthene Inc at Maxim Group's Institutional NYC BioDefense Mini-Conference Add to calendar
Sep 8, 2014
PharmAthene, Inc. at Rodman & Renshaw Global Investment Conference
Aug 7, 2014
Q2 2014 PharmAthene, Inc. Earnings Release- Tentative
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -12.00% -65.42%
Operating margin -31.97% -60.51%
EBITD margin - -59.49%
Return on average assets -11.90% -58.77%
Return on average equity -18.36% -123.29%
Employees 52 -
CDP Score - -

Address

Suite #450, One Park Place
ANNAPOLIS, MD 21401
United States - Map
+1-410-2692600 (Phone)
+1-410-2692601 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

PharmAthene, Inc. is a biodefense company engaged in the development and commercialization of medical countermeasures against biological and chemical threats. As of December 31, 2011, the Company�s biodefense portfolio of product candidates included SparVax, a second generation recombinant protective antigen (rPA) anthrax vaccine; Valortim, a fully human monoclonal antibody for the prevention and treatment of anthrax infection, and rBChE (recombinant butyrylcholinesterase) bioscavanger, a medical countermeasure for nerve agent poisoning by organophosphorous compounds, including nerve gases and pesticides.

Officers and directors

Mitchel B. Sayare Ph.D. Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Eric I. Richman President, Chief Executive Officer, Director
Age: 53
Bio & Compensation  - Reuters
Linda L. Chang Chief Financial Officer, Senior Vice President
Age: 48
Bio & Compensation  - Reuters
Francesca M. Cook Senior Vice President - Policy and Government Affairs
Age: 49
Bio & Compensation  - Reuters
Wayne Morges Ph.D. Senior Vice President - Regulatory Affairs and Quality
Age: 67
Bio & Compensation  - Reuters
Arthur Y. Elliott Ph.D. Acting Chief Scientific Officer
Age: 78
Bio & Compensation  - Reuters
John M. Gill Independent Director
Age: 62
Bio & Compensation  - Reuters
Brian A. Markison Independent Director
Age: 54
Bio & Compensation  - Reuters
Joel W. McCleary Independent Director
Age: 65
Bio & Compensation  - Reuters
Jeffrey W. Runge M.D. Independent Director
Age: 58
Bio & Compensation  - Reuters